Connor Clark & Lunn Investment Management Ltd. Invests $1.98 Million in The Cooper Companies, Inc. (NASDAQ:COO)

Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 21,586 shares of the medical device company’s stock, valued at approximately $1,984,000.

Several other institutional investors have also recently made changes to their positions in the business. Fulton Bank N.A. raised its holdings in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock worth $342,000 after purchasing an additional 109 shares during the last quarter. Torray Investment Partners LLC raised its holdings in shares of Cooper Companies by 0.8% during the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after purchasing an additional 132 shares during the last quarter. Mather Group LLC. raised its holdings in shares of Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after purchasing an additional 133 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after purchasing an additional 136 shares during the last quarter. Finally, Greenleaf Trust raised its holdings in shares of Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock worth $268,000 after purchasing an additional 139 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Stifel Nicolaus reduced their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, March 7th. Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Morgan Stanley cut their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Finally, Citigroup cut their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $111.89.

Cooper Companies Stock Up 0.2 %

COO stock opened at $80.04 on Wednesday. The stock has a market capitalization of $16.01 billion, a P/E ratio of 41.05, a P/E/G ratio of 2.25 and a beta of 1.02. The firm has a 50-day simple moving average of $90.68 and a 200-day simple moving average of $98.56. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 52 week low of $77.05 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts’ consensus estimates of $0.92. The business had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.